About Marco Cannizzo

Marco Cannizzo focuses his practice on real estate, corporate, foreign investments and M&A transactions, with about 27 years of experience. He acts as counsel for several Italian pharmaceutical companies doing business in Mexico, including Alfasigma, Recordati Rare Diseases, Kedrion and SIFI. He has been involved and has acted as leading counsel in many strategic transactions in Mexico, some of them for several hundred million dollars, including the sales of insurance companies, hotel chains and large retail spaces. He is a member of the board or the secretary of several Mexican companies, some of which are listed on the Mexican Stock Exchange.